Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 1100 of 3173 entries
View as:

A Study To Evaluate The Effect Of Rifampin On Pharmacokinetics Of PF-06463922 In Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02804399 Org: User:
Start: 07/31/16 End: 10/31/16 Due: 10/31/17

A Study to Learn About the Study Medicine Called PF-07868489 in Healthy Adult People and in People With Pulmonary Arterial Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT06137742 Org: User:
Start: 11/17/23 End: 02/13/27 Due: 02/13/28

Transition Study: Growth Hormone Therapy In Partial Growth Hormone Deficient Adolescents

Phase: N/A Priority: Normal
NCT ID: NCT00156143 Org: User:
Start: 04/30/02 End: 04/30/05 Due: 04/30/06

Study of Safety And Efficacy Of ReFacto AF In Previously Untreated Hemophilia A Patients In The Usual Care Setting

Phase: N/A Priority: Normal
NCT ID: NCT00950170 Org: User:
Start: 02/10/10 End: 11/24/16 Due: 11/24/17

A Pilot Study of Fluconazole Plus Flucytosine for the Treatment of AIDS Patients With Acute Cryptococcal Meningitis.

Phase: N/A Priority: Normal
NCT ID: NCT00002113 Org: User:
Start: - End: - Due: -

4-Week, Multiple-dose, Dose-escalating Study In Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT03538743 Org: User:
Start: 06/25/18 End: 06/10/19 Due: 06/10/20

A Trial To Evaluate A Multivalent Pneumococcal Conjugate Vaccine In Healthy Adults 50-85 Years Of Age

Phase: N/A Priority: Normal
NCT ID: NCT03313050 Org: User:
Start: 10/12/17 End: 05/24/19 Due: 05/24/20

Real-world Therapy of ALK-positive NSCLC in Sweden: the Sequencing of ALK Tyrosine Kinase Inhibitor Drugs and Their Therapeutic Outcomes Based on Data From National Registers.

Phase: N/A Priority: Normal
NCT ID: NCT04647110 Org: User:
Start: 12/14/20 End: 03/15/21 Due: 03/15/22

A Phase 1 Single/Multiple Dose Study Of PF-06293620 To Assess Safety, Tolerability And Pharmacokinetics In Subjects With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT02211261 Org: User:
Start: 09/15/14 End: 01/27/17 Due: 01/27/18

A Study to Learn More About the Study Medicine PF-07264660 in Healthy Chinese Adult Participants

Phase: N/A Priority: Normal
NCT ID: NCT06712082 Org: User:
Start: 02/24/25 End: 08/31/25 Due: 08/31/26

The Study Of Azithromycin Switch Therapy For Treatment Of Community Acquired Pneumonia (CAP)

Phase: N/A Priority: Normal
NCT ID: NCT00809328 Org: User:
Start: 02/28/09 End: 03/31/10 Due: 03/31/11

Hepatic Impairment Study for Lorlatinib in Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT03726333 Org: User:
Start: 01/14/20 End: 07/08/21 Due: 07/08/22

Immediate vs. Deferred Empirical Antifungal Treatment With Voriconazole In Neutropenic Patients

Phase: N/A Priority: Normal
NCT ID: NCT00150345 Org: User:
Start: 01/31/05 End: 04/30/09 Due: 04/30/10

Vfend Special Investigation For Prophylaxis

Phase: N/A Priority: Normal
NCT ID: NCT02674685 Org: User:
Start: 03/11/16 End: 07/03/19 Due: 07/03/20

Special Investigation For Long Term Use Of Tolterodine (Regulatory Post Marketing Commitment Plan).

Phase: N/A Priority: Normal
NCT ID: NCT00795509 Org: User:
Start: 08/31/07 End: 03/31/11 Due: 03/31/12

The Safety and Efficacy of Intravenous Anidulafungin as a Treatment for Azole-Refractory Mucosal Candidiasis (FRMC)

Phase: N/A Priority: Normal
NCT ID: NCT00041704 Org: User:
Start: 08/31/02 End: 08/31/04 Due: 08/31/05

A Drug-Drug Interaction Study Between PF-06882961 and PF-06865571 in Healthy Adult Participants and Overweight Adults or Adults With Obesity Who Are Otherwise Healthy

Phase: N/A Priority: Normal
NCT ID: NCT04839393 Org: User:
Start: 04/05/21 End: 11/08/21 Due: 11/08/22

Ceftazidime-Avibactam Compared With Doripenem Followed by Oral Therapy for Hospitalized Adults With Complicated UTIs (Urinary Tract Infections)

Phase: N/A Priority: Normal
NCT ID: NCT01599806 Org: User:
Start: 10/31/12 End: 08/31/14 Due: 08/31/15

A Multicentre, Double-Blind, Double-Dummy, Randomised Study of the Analgesic Efficacy and Safety of Valdecoxib Compared to Diclofenac Sodium in Patients Undergoing Knee Arthroscopy for Anterior Cruciate Ligament (ACL) Reconstruction

Phase: N/A Priority: Normal
NCT ID: NCT00650598 Org: User:
Start: 03/31/04 End: 08/31/04 Due: 08/31/05

A Study To Estimate The Effect of PF-06650833 On The Pharmacokinetics (PK) of Oral Contraceptive (OC)

Phase: N/A Priority: Normal
NCT ID: NCT05064332 Org: User:
Start: 10/08/21 End: 12/16/21 Due: 12/16/22

PF-06372865 in Subjects With Photosensitive Epilepsy

Phase: N/A Priority: Normal
NCT ID: NCT02564029 Org: User:
Start: 12/16/15 End: 02/07/17 Due: 02/07/18

Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) in Adult Outpatients With Major Depressive Disorder (MDD)

Phase: N/A Priority: Normal
NCT ID: NCT01432457 Org: User:
Start: 10/31/11 End: 08/31/12 Due: 08/31/13

Study Of AG-013736 In Patients With 131I-Refractory Thyroid Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00389441 Org: User:
Start: 12/31/06 End: 09/30/12 Due: 09/30/13

A Clinical Trial To Assess Fesoterodine On Treatment Satisfaction And Symptom Improvement In Overactive Bladder Patients

Phase: N/A Priority: Normal
NCT ID: NCT00425100 Org: User:
Start: 01/31/07 End: 10/31/07 Due: 10/31/08

A Trial Evaluating a 7-valent Pneumococcal Conjugate Vaccine Given With Diphtheria, Tetanus, and Acellular Pertussis Vaccine (DTaP) in Healthy Japanese Infants.

Phase: N/A Priority: Normal
NCT ID: NCT01250756 Org: User:
Start: 11/30/10 End: 03/31/12 Due: 03/31/13